Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use MOZOBIL safely and effectively. See full prescribing information for MOZOBIL. MOZOBIL® (plerixafor) injection, for subcutaneous use Initial U.S. Approval: 2008
Medication labelWhy this: Advisory · dailymed-prescription
Mozobil is indicated in combination with filgrastim to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma (NHL) or multiple myeloma (MM).
- generic_name
- plerixafor
- product_names
- PLERIXAFOR
- ndc
- 0024-5862, 0024-5862-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en